PT Kalbe Farma Tbk. (PTKFF) Stock Price, News & Analysis

Company Overview

PT Kalbe Farma Tbk is a leading Indonesian pharmaceutical and healthcare company founded in 1966 and headquartered in Jakarta. As one of the largest pharmaceutical firms in Southeast Asia, Kalbe Farma develops, manufactures and distributes a broad range of products across prescription pharmaceuticals, consumer health, nutritionals, distribution and logistics services, as well as clinical laboratory testing.

In its prescription pharmaceutical segment, Kalbe Farma produces a variety of branded and generic medicines spanning therapeutic areas such as cardiovascular, gastrointestinal, oncology and central nervous system disorders. The consumer health division offers over-the-counter products, including vitamins, minerals and herbal supplements, while its nutritionals segment specializes in infant formula, medical nutrition and adult health supplements designed for specialized dietary needs.

The company operates an extensive distribution network across Indonesia and exports its products to more than 30 countries in Asia, the Middle East and Africa. In addition to its main manufacturing facilities in East Java and West Java, Kalbe Farma maintains regional offices in Singapore, Malaysia, the Philippines, Taiwan and Vietnam, as well as cold-chain logistics capabilities to support its broad product portfolio.

Kalbe Farma invests in research and development through its dedicated R&D centers, focusing on innovative drug delivery systems and new nutraceutical formulations. The company is led by President Director Vidjongtius and a management team that emphasizes sustainable growth, regulatory compliance and strategic partnerships to expand its footprint in both domestic and international markets.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.06 to $0.10
• 52-Week Range: $0.06 to $0.10
• Volume: N/A
• Average Volume: 28,500 shs
• Market Capitalization: N/A
• P/E Ratio: 0.00
• Dividend Yield: 23,083.07%
• Price Target: N/A
• Consensus Rating: N/A

PTKFF Stock Analysis - Frequently Asked Questions

How have PTKFF shares performed this year?

PT Kalbe Farma Tbk.'s stock was trading at $0.0951 at the start of the year. Since then, PTKFF shares have decreased by 34.1% and is now trading at $0.0626.

How do I buy shares of PT Kalbe Farma Tbk.?

Shares of PTKFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PTKFF
• CIK: N/A
• Web: www.kalbe.co.id
• Phone: 622142873888
• Fax: N/A
• Employees: 13,062
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A